CRISPR pioneer Doudna envisions a world of woolly mammoths and unicorns

In new book, biochemist Jennifer Doudna envisions a world of woolly mammoths, winged lizards, and unicorns as CRISPR "allows us to bend nature to our will."
Jennifer Doudna of the University of California, Berkeley

If there was one misstep that doomed the long and bitter fight by the University of California to wrest key CRISPR patents from the Broad Institute, it was star UC Berkeley scientist Jennifer Doudna’s habit of being scientifically cautious, realistic, and averse to overpromising.

A biochemist who co-led a breakthrough 2012 study of CRISPR-Cas9, Doudna repeatedly emphasized in interviews the challenges of repurposing the molecular system, which bacteria use to fend off viruses, to edit human genomes. The U.S. patent office, in a February ruling that let the Broad keep its CRISPR patents (for now), relied heavily on those statements — “We weren’t sure if CRISPR/Cas9 would work in … animal cells,” for example — to conclude that when scientists

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readSociety
Google Partners With Major U.S. Health System, Gaining Access To Vast Patient Data In The Process
Google has quietly launched a project with one of the nation’s largest nonprofit health systems in which it has gained access to millions of patient records.
STAT3 min readPolitics
More Than Ever, Democratic Presidential Hopefuls Want To Take On Pharma. Here’s How They’d Do It
Democratic candidates' policies focus on three distinct areas: allowing direct Medicare negotiation, allowing importation, and fostering generic drug competition. 
STAT3 min read
Opinion: My Life Depends On Medicine Made From Plasma. The Plasma Shortage Worries Me
Just out of college, a rare disease diagnosis wasn't in my plan. Two decades later, I still feel mentally and physically strong and full of hope for my future, thanks…